Fibrous tubular conduit for stenting applications
US-2024189124-A1 · Jun 13, 2024 · US
US9259334B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9259334-B2 |
| Application number | US-201313766530-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 13, 2013 |
| Priority date | Feb 13, 2012 |
| Publication date | Feb 16, 2016 |
| Grant date | Feb 16, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A device for treating a damaged tissue includes an expandable scaffold positionable in a portion of a luminal tissue structure of a mammal; and maintained via stent technology, wherein the scaffold is comprised of electrospun fibers composed of a biodegradable compound. The scaffold serves as a temporary template that allows the tissue to be rebuilt.
Opening claim text (preview).
What is claimed is: 1. A device for vascular tissue repair comprising: a cell permeable diametrically expandable intraluminal scaffold composed of nonwoven fibers having an average porosity from about 70% to about 85%, a luminal surface comprising substantially curvilinear nonwoven fibers facing the lumen of the vascular tissue, and an abluminal surface comprising substantially linear fibers facing the luminal wall of the vascular tissue, wherein the scaffold has an ultimate tensile strength in the range of about 1.45±0.32 MPa to about 1.893±0.458 MPa. 2. The device of claim 1 , wherein the fibers are composed of biodegradable material and/or a bioresorbable material. 3. The device of claim 1 , wherein the scaffold is composed of on ore more poly(α-hydroxy esters). 4. The device of claim 1 , wherein scaffold is composed of polycaprolactone. 5. The device of claim 1 , wherein the scaffold is composed of natural polymers that are biodegradable and/or bioresorbable. 6. The device of claim 1 , wherein the scaffold is composed of elastin, collagen, DNA, RNA, glucosaminoglycans, polyhydroxyalkanoates or mixtures thereof. 7. The device of claim 1 , wherein the luminal surface is a concave surface and wherein the abluminal surface is a convex surface. 8. The device of claim 1 , wherein the scaffold is supported by a supporting structure. 9. The device of claim 8 , wherein the supporting structure is expandable. 10. The device of claim 8 , wherein the supporting structure is an expandable stent. 11. The device of claim 8 , wherein the supporting structure is a pliant structure. 12. The device of claim 8 , wherein the supporting structure is a repositionable structure. 13. The device of claim 8 , wherein the supporting structure is bioresorbable and/or biodegradable. 14. The device of claim 1 , wherein the scaffold is substantially tubular. 15. The device of claim 1 , wherein the scaffold is supported by at least a portion of a medical device. 16. The device of claim 1 , wherein the scaffold is sutured or mechanically affixed to a supporting structure. 17. The device of claim 1 , wherein the scaffold chemically adheres to a supporting structure. 18. The device of claim 1 , wherein a supporting structure is incorporated into the electrospun scaffold. 19. The device of claim 1 , wherein the fibers are treated with chemical or therapeutic agents or are treated with gas plasma. 20. A method of repairing vascular tissue comprising: providing a cell permeable diametrically expandable intraluminal scaffold with an average porosity from about 70% to about 85% comprised of nonwoven fibers, a luminal surface of the intraluminal scaffold comprising substantially curvilinear fibers facing a lumen of the vascular tissue, and an abluminal surface comprising substantially linear fibers facing an interior wall of the vascular tissue, wherein the scaffold has an ultimate tensile strength in the range of about 1.45±0.32 MPa to about 1.893±0.458 MPa; inserting the scaffold into a luminal area of the vascular tissue expanding the scaffold such that the scaffold contacts at least a portion of the vascular tissue structure, wherein the scaffold is positioned such that the luminal surface of the scaffold provides attachment cell attachment surface while the abluminal surface allows for ingress and organization of cells; and securing the scaffold in the vascular tissue structure. 21. The method of claim 20 wherein the vascular tissue structure of the inserting step is aneurysmal. 22. The method of claim 20 wherein the nonwoven fibers are comprised from a biodegradable material and/or a bioresorbable material.
by electro-spinning {(electro-spinning methods and apparatus D01D5/0007)} · CPC title
Materials at least partially resorbable by the body · CPC title
Stent-grafts · CPC title
Porous materials, e.g. foams or sponges · CPC title
Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.